Results 111 to 120 of about 549,087 (258)

Editorial: Venoms and Toxins: At the Crossroads of Basic, Applied and Clinical Immunology. [PDF]

Front Immunol, 2021
Pucca MB, Fry BG, Sartim MA, Peigneur S, Monteiro WM.   +4 more
europepmc   +1 more source

Retractions in Rheumatology: Trends, Causes, and Implications for Research Integrity

Arthritis Care &Research, EarlyView.
Objective We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods We reviewed the Retraction Watch database to identify retracted articles in rheumatology. We recorded the main study characteristics, authors’ countries, reasons for retraction, time from publication to retraction, and trends over time ...
Anna Maria Vettori, Michele Iudici
wiley   +1 more source

Clinical and immunological outcomes after randomized trial of baked milk oral immunotherapy for milk allergy

JCI Insight
BACKGROUND Cow’s milk (CM) allergy is the most common food allergy in young children. Treatment with oral immunotherapy (OIT) has shown efficacy, but high rates of adverse reactions.
Jennifer A. Dantzer, Sloan A. Lewis, Kevin J. Psoter, Aaron Sutherland, April Frazier, Eve Richardson, Synaida Maiche, Gregory Seumois, Bjoern Peters, Robert A. Wood   +9 more
doaj   +1 more source

AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper. [PDF]

Allergy, 2022
Bergmann C, Poli A, Agache I, Bianchini R, Bax HJ, Castells M, Crescioli S, Dombrowicz D, Ferastraoaru D, Fiebiger E, Gould HJ, Hartmann K, Izquierdo E, Jordakieva G, Josephs DH, Jutel M, Levi-Schaffer F, de Las Vecillas L, Lotze MT, Osborn G, Pascal M, Redegeld F, Rosenstreich D, Roth-Walter F, Schmidt-Weber C, Shamji M, Steveling EH, Turner MC, Untersmayr E, Jensen-Jarolim E, Karagiannis SN.   +30 more
europepmc   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors

JCI Insight
BACKGROUND Inhibition of Bruton’s tyrosine kinase with ibrutinib blocks the function of myeloid-derived suppressor cells (MDSC). The combination of ibrutinib and nivolumab was tested in patients with metastatic solid tumors.METHODS Sixteen patients ...
Emily Schwarz, Brooke Benner, Robert Wesolowski, Dionisia Quiroga, Logan Good, Steven H. Sun, Himanshu Savardekar, Jianying Li, Kyeong Joo Jung, Megan C. Duggan, Gabriella Lapurga, Jami Shaffer, Luke Scarberry, Bhavana Konda, Claire Verschraegen, Kari Kendra, Manisha Shah, Robert Rupert, Paul Monk, Hiral A. Shah, Anne M. Noonan, Kristin Bixel, John Hays, Lai Wei, Xueliang Pan, Gregory Behbehani, Yang Hu, Olivier Elemento, Dongjun Chung, Gang Xin, Bradley W. Blaser, William E. Carson III   +31 more
doaj   +1 more source

Characterizing telemedicine use in clinical immunology and allergy in Canada before the COVID-19 pandemic. [PDF]

Allergy Asthma Clin Immunol, 2021
Lee EY, Song C, Vadas P, Morgan M, Betschel S.   +4 more
europepmc   +1 more source

Clinical Immunology [PDF]

Journal of Clinical Pathology, 1972
  +5 more sources

Clinical immunology in chromatinopathies: a scoping review. [PDF]

Front Immunol
Jans D, Al B, Bouman A, Geelen JM, Kleefstra T, Placek K.   +5 more
europepmc   +1 more source

Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce. [PDF]

Clin Transl Allergy, 2023
Asllani J, Mitsias D, Konstantinou G, Mesonjesi E, Xhixha F, Shehu E, Christoff G, Noleva K, Makris M, Aggelidis X, Turkalj M, Damir E, Agache I, Tomic-Spiric V, Stosovic R, Misirligil Z, Kosnik M, Popov TA, Calderon M, Papadopoulos NG, ADER study group.   +20 more
europepmc   +1 more source